tiprankstipranks
Trending News
More News >
Cingulate Inc Terminates Grant Agreement with Foundation
PremiumCompany AnnouncementsCingulate Inc Terminates Grant Agreement with Foundation
2M ago
Cingulate Inc. Receives Buy Rating Amid Promising Developments in ADHD Treatment CTx-1301
Premium
Ratings
Cingulate Inc. Receives Buy Rating Amid Promising Developments in ADHD Treatment CTx-1301
2M ago
Cingulate announces results from high-dose fed/fast study of CTx-1301
Premium
The Fly
Cingulate announces results from high-dose fed/fast study of CTx-1301
2M ago
Cingulate Inc. Reports 2024 Financial and Development Milestones
PremiumCompany AnnouncementsCingulate Inc. Reports 2024 Financial and Development Milestones
3M ago
Cingulate sees cash runway sufficient into Q4
Premium
The Fly
Cingulate sees cash runway sufficient into Q4
3M ago
Promising Prospects for Cingulate Inc.: Buy Rating Backed by Positive Phase 3 Results and Market Potential of CTx-1301
Premium
Ratings
Promising Prospects for Cingulate Inc.: Buy Rating Backed by Positive Phase 3 Results and Market Potential of CTx-1301
4M ago
Cingulate initiated with a Buy at Roth MKM
PremiumThe FlyCingulate initiated with a Buy at Roth MKM
6M ago
Cingulate Inc Completes Key FDA Study for ADHD Drug
Premium
Company Announcements
Cingulate Inc Completes Key FDA Study for ADHD Drug
6M ago
Cingulate completed final FDA-required study for CTx-1301 for ADHD
Premium
The Fly
Cingulate completed final FDA-required study for CTx-1301 for ADHD
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100